The Role of Mushroom Nutrition as A Delivery Agent for Enzyme Therapy in Cancer Care?
Chemical and Biological Properties in Mushroom Nutrition
In this abstract, Professor Karmali examines the in vitro content of lacasse activity, protease activity, peroxidase activity and glycomylase activity (glycose-2-oxidase) of various mushrooms (Grifola frondosa, Ganoderma lucidium, Cordyceps sinensis and Coriolus versicolor ) per 500 mg tablet.
Presented at the 4th International Symposium on Mushroom Nutrition, University of Westminster, June 15th, 2002.
To contact Professor Karmali
Biotechnology Section
Instituto Superior de Engenharia de Lisboa (ISEL)
Tel:351-21-831-7052 / Fax:351-21-831-7267
Email: akarmali@isel.ipl.pt
Clinical Articles
The following section outlines the clinical papers, posters and proposals that refer to the clinical use of MRL mushroom nutrition products. This information is for healthcare practitioners only and should not be provided to members of the general public.
Download PDF
Clinical articles
-
Mushroom Nutrition In Neurodegenerative Diseases
Prof. Vittorio Calabrese
Faculty of Medicine, University of Catania and University of Messina, Italy -
Targeting Neurogenesis with Mushroom Nutrition: A Mini Review
Dr. Elisabete Ferreiro, CNC-Center for Neuroscience and Cell Biology
CIBB-Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal
Prof. Tito Fernandes, CIISA
Faculty of Veterinary Medicine, Lisbon University, Lisbon, Portugal -
Central Nervous System Profiling of Hericium erinaceus Biomass Powder by an Electropharmacogram Using Spectral Field Power in Conscious Freely Moving Rats
Prof. Wilfried Dimpfel Justus
Liebig-University Giessen, Germany
Dr. Julie Wiebe
Nektium Pharm S.L., Las Palmas, Spain
Dr. Nigel Gericke, Gericke Consulting
Baden, Switzerland
-
A TCM Perspective on Mushroom Nutrition: Hericium erinaceus and Trametes versicolor (synn. Coriolus versicolor) as a synergistic combination
Karel Simonovsky and Zuzana Vancurikova